Hancock Jaffe Laboratories, Inc. (HJLI) is a publicly traded company in the Unknown sector. Across all available filings, 9 corporate insiders have executed 48 transactions totaling $1.8M, demonstrating a bearish sentiment with -$1.5M in net insider flow. The most recent transaction on Aug 25, 2021 involved a purchase of 1,300 shares valued at $10.0K.
No significant insider buying has been recorded for HJLI in the recent period.
No significant insider selling has been recorded for HJLI in the recent period.
Based on recent SEC filings, insider sentiment for HJLI is bearish with an Insider Alignment Score of 8/100 and a net flow of -$1.5M. Insiders are reducing their positions, though this can be driven by factors unrelated to company outlook.
Insider trading at Hancock Jaffe Laboratories, Inc. (HJLI) refers to stock transactions made by corporate insiders—executives, directors, and beneficial owners holding more than 10% of the company's shares. These individuals have access to material non-public information and are required by law to report their trades to the SEC within two business days. Currently, 9 insiders are actively trading HJLI stock, having executed 48 transactions in the past 90 days. The most active insider is Holding, S.a. Biodyne (Executive), who has made 33 transactions totaling $1.7M.
Get notified when executives and directors at HJLI file new Form 4 transactions
Date | Insider | Title | Type | Shares | Price | Value | Flags |
|---|---|---|---|---|---|---|---|
| Aug 25, 2021 | Jenusaitis Matthew | Executive | Purchase | 1,300 | $7.70 | $10.0K | |
| Jun 16, 2021 | Gray Robert | Executive | Purchase | 2,000 | $6.25 | $12.5K | |
| May 21, 2021 | H. Glickman Marc | Executive | Purchase | 1,600 | $5.90 | $9.4K | |
| May 18, 2021 | Andrew Berman Robert | Executive | Purchase | 3,000 | $5.47 | $16.4K | |
| May 17, 2021 | Duhay Francis | Executive | Purchase | 9,492 | $5.33 | $50.6K | |
| Aug 21, 2020 | S.a. Biodyne Holding, | Executive | Sale | 75,000 | $0.38 | $28.5K | |
| Aug 20, 2020 | S.a. Biodyne Holding, | Executive | Sale | 75,000 | $0.27 | $20.3K | |
| Aug 19, 2020 | S.a. Biodyne Holding, | Executive | Sale | 50,000 | $0.30 | $15.0K | |
| Aug 18, 2020 | S.a. Biodyne Holding, | Executive | Sale | 50,000 | $0.34 | $17.0K | |
| Aug 14, 2020 | S.a. Biodyne Holding, | Executive | Sale | 50,000 | $0.31 | $15.5K | |
| Aug 3, 2020 | S.a. Biodyne Holding, | Executive | Sale | 70,000 | $0.32 | $22.4K | |
| Jul 31, 2020 | S.a. Biodyne Holding, | Executive | Sale | 5,000 | $0.34 | $1.7K | |
| Jul 30, 2020 | S.a. Biodyne Holding, | Executive | Sale | 25,000 | $0.32 | $8.0K | |
| Jul 21, 2020 | S.a. Biodyne Holding, | Executive | Sale | 50,000 | $0.45 | $22.5K | |
| Jul 20, 2020 | S.a. Biodyne Holding, | Executive | Sale | 150,000 | $0.43 | $64.5K |
| TYPE | COUNT | VALUE | % |
|---|---|---|---|
Sale(S) | 32 | $1.7M | 81.7% |
Award(A) | 8 | $225.0K | 11.0% |
Purchase(P) | 7 | $149.0K | 7.3% |
Other(J) | 1 | $0 | 0.0% |
Insider selling pressure at Hancock Jaffe Laboratories, Inc. has increased, with 9 insiders executing 48 transactions across all time. Total sales of $1.7M significantly outpace purchases of $149.0K, resulting in a net outflow of $1.5M. This selling activity appears largely discretionary, which may warrant closer attention from investors.